Taisho Pharmaceutical Co., Ltd. entered into a share purchase arrangement to acquire an additional 8.14% stake in Biofermin Pharmaceutical Co., Ltd. (TSE:4517) from Takeda Pharmaceutical Company Limited (TSE:4502) on July 31, 2013. Taisho Pharmaceutical already holds 6.7 million shares of Biofermin Pharmaceutical and following the completion of the deal, Taisho Pharmaceutical will hold 7.6 million shares of Biofermin Pharmaceutical. The Board of Directors of Taisho Holdings passed the resolution on July 31, 2013.

The transaction is expected to close on August 5, 2013. The impact of the share purchase arrangement on consolidated operating results of Taisho Holdings is expected to be immaterial.